Navigation Links
Deep Brain Stimulation Works in Two Sites for Parkinson's Disease
Date:6/2/2010

Choice of area to pinpoint can be tailored to individual patients, researchers say ,,

WEDNESDAY, June 2 (HealthDay News) -- People suffering from Parkinson's disease can benefit from deep brain stimulation in either one of two sites in the brain, a new study finds.

The Veterans Affairs researchers compared two different targets in the brain for deep brain stimulation -- the subthalamic nucleus (STN) and the globus pallidus interna (GPi) -- both of which affect motor function. The procedure involves placing a fine wire into either of the two areas, after which an implanted battery delivers a finely tuned electrical current to stimulate the brain, often resulting in dramatic improvement in motor function.

"Most of the neurosurgery field has been using the STN target, with little strong evidence that it was the best target for stimulation," said researcher Frances Weaver, director of the Center for Management of Complex Chronic Care at Hines VA Hospital in Illinois.

"But recent reports suggest that there may be some negative consequences of STN targeting, including cognitive and psychological changes," she added.

The report is published in the June 3 issue of the New England Journal of Medicine.

For this study, researchers compared the STN and GPi targets in a randomized trial and looked at patient outcomes. In the trial, 299 patients were assigned to either STN or GPi deep brain stimulation.

Weaver's team found that patients improved equally in motor function, regardless of which target was used.

Overall, about half of the patients had serious side effects. The most common was infection at the incision site. By the end of the two-year study, 99 percent of these side effects were resolved.

"The decision as to which target in the brain to stimulate to treat Parkinson's disease should consider the other symptoms and problems of Parkinson's disease," Weaver said. For example, the use of medications can be reduced to a greater extent after STN stimulation than GPi stimulation, she noted.

"Medication has effects on other symptoms, so if a patient is experiencing other symptoms besides motor problems that are better managed by medication, you may want to select the GPi -- where less reduction in medication is necessary," Weaver said.

Both STN and GPi deep brain stimulation are equally effective in improving motor symptoms in people with advanced Parkinson's disease, Weaver said.

"Serious adverse events are frequent for both targets, but are resolved through stimulation or medication adjustments, and other interventions, as needed," she added.

Dr. Michael Okun, national medical director of the National Parkinson Foundation, said that "this is an important study for Parkinson's disease patients and for their doctors as it opens the door for tailoring therapy and for tailoring brain targets for individual symptom profiles."

He added: "This two-year prospective randomized study showed that both STN and GPi were effective in treating the motor symptoms of Parkinson's disease, and that there were subtle but potentially important differences between targets."

The first signs of Parkinson's are usually motor control problems such as shaking, rigidity, slowed movement and poor balance. In later stages, patients develop a variety of cognitive and mood problems, including depression, apathy, slowed thinking, confusion, impaired memory and trouble sleeping.

In early stages of the disease, motor symptoms can be controlled by medications such as L-dopa. But for patients with advanced Parkinson's, the drugs are less effective.

More information

For more information on Parkinson's disease, visit the National Parkinson Foundation.



SOURCES: Frances Weaver, Ph.D., director, Center for Management of Complex Chronic Care, Hines VA Hospital, Hines, Ill.; Michael Okun, M.D., national medical director, National Parkinson Foundation; June 3, 2010, New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Hope for Brain, Spinal Cord Injuries
2. UPMC Health Plan Offers Brain Fitness Software to Improve Health
3. NFL Brain Injury Panel Raises Awareness of Potential Long-Term Consequences from Traumatic Brain Injuries
4. Melatonin precursor stimulates growth factor circuits in brain
5. Brain Scans Suggest Some Vegetative Patients May Be Aware
6. Brain Damage Seen in People With Severe Sleep Apnea
7. Alterations in the brains reward system related to attention-deficit/hyperactivity disorder
8. Brain dopamine receptor density correlates with social status
9. 3 brain diseases linked by toxic form of same neural protein
10. Brain Damage: NFL ‘Gets It,' American Society of Anesthesiologists Still Appears ‘Asleep'
11. Study finds reduced brain gray matter concentration in patients with severe obstructive sleep apnea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, NC introduce ... a solid foundation. As experts in dangerous situations the Inflow IQ team can ... Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
(Date:3/23/2017)... FL (PRWEB) , ... March 23, 2017 , ... The ... that 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and ... those who have contributed not only to the association, but also to the Health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The founders of Dr. Wang ... winners of American Dreams & Good Housekeeping Seal Initiative, a nationwide search for ... Good Housekeeping. , Steven Wang, MD ., a renowned dermatologist and medical ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance Institute on March ... the coding audit process for all medical chart types with a comprehensive set ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... India , March 23, 2017 ... - 2021, a latest research report. The global vagus ... is shift of surgeons focus toward minimally invasive VNS ... or limited to few developed countries having high standards ... ...
(Date:3/22/2017)... Colo. , March 22, 2017 ... in the development of Ampion™, a low molecular ... properties, today announced that it is re-issuing its previous ... to incorporate certain disclosures that are required under ... 610(b). Included below are these additional disclosures along with ...
(Date:3/22/2017)... March 22, 2017  CANTEL MEDICAL CORP. (NYSE: ... President and CEO, will be presenting at the 16 th ... Grand Central Hotel in New York . ... at 3:00 p.m. ET. In addition, management will be available ... A live audio webcast will be available via the investor ...
Breaking Medicine Technology: